Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

113 questions · 119 findings · 12 reviews · Urology

No studies found 38 · 31.9%GRADE not reported 0 · 0%Very low 43 · 36.1%Low 21 · 17.6%Moderate 16 · 13.4%High 1 · 0.8%

Non‐steroidal antiandrogen monotherapy vs LHRH agonists or surgical castration monotherapy

Overall survival · men with advanced prostate cancer

Non‐steroidal antiandrogen monotherapy probably leads to higher overall survival compared with LHRH agonists or surgical castration monotherapy (moderate certainty).

1 finding from 1 review

Non‐steroidal antiandrogen monotherapy vs LHRH agonists or surgical castration monotherapy

Clinical progression · men with advanced prostate cancer

Non‐steroidal antiandrogen monotherapy probably leads to higher clinical progression compared with LHRH agonists or surgical castration monotherapy (moderate certainty).

1 finding from 1 review

Non‐steroidal antiandrogen monotherapy vs LHRH agonists or surgical castration monotherapy

Treatment failure · men with advanced prostate cancer

Non‐steroidal antiandrogen monotherapy probably leads to higher treatment failure compared with LHRH agonists or surgical castration monotherapy (moderate certainty).

1 finding from 1 review

Non‐steroidal antiandrogen monotherapy vs LHRH agonists or surgical castration monotherapy

Breast pain · men with advanced prostate cancer

Non‐steroidal antiandrogen monotherapy probably leads to higher breast pain compared with LHRH agonists or surgical castration monotherapy (moderate certainty).

1 finding from 1 review

Non‐steroidal antiandrogen monotherapy vs LHRH agonists or surgical castration monotherapy

Gynaecomastia · men with advanced prostate cancer

Non‐steroidal antiandrogen monotherapy probably leads to higher gynaecomastia compared with LHRH agonists or surgical castration monotherapy (moderate certainty).

1 finding from 1 review

Non‐steroidal antiandrogen monotherapy vs LHRH agonists or surgical castration monotherapy

Hot flashes · men with advanced prostate cancer

Non‐steroidal antiandrogen monotherapy probably leads to lower hot flashes compared with LHRH agonists or surgical castration monotherapy (moderate certainty).

1 finding from 1 review

Injectional nicardipine vs Normal saline

Treatment‐related adverse effects · men with chronic Peyronie's disease (plaques without calcification)

It is very uncertain whether injectional nicardipine changes treatment‐related adverse effects compared with saline (very low certainty).

1 finding from 1 review